J. Chris Culberson
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Advanced Chemical Physics Studies, Computational Drug Discovery Methods, Atomic and Molecular Physics, Spectroscopy and Quantum Chemical Studies, Neuroendocrine regulation and behavior
Most-Cited Works
- → Comparison of Topological, Shape, and Docking Methods in Virtual Screening(2007)415 cited
- → Localized orbitals based on the fermi hole(1984)143 cited
- → An intermediate neglect of differential overlap (INDO) technique for lanthanide complexes: studies on lanthanide halides(1987)97 cited
- → 1-(((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo[2.2.1]heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperazine (L-368,899): An Orally Bioavailable, Non-Peptide Oxytocin Antagonist with Potential Utility for Managing Preterm Labor(1994)92 cited
- → Molecular Transformations as a Way of Finding and Exploiting Consistent Local QSAR(2005)90 cited
- → Structure-Based Design of HIV-1 Protease Inhibitors: Replacement of Two Amides and a 10.pi.-Aromatic System by a Fused Bis-tetrahydrofuran(1994)69 cited
- → Human Immunodeficiency Virus Type 1 Protease Inhibitors: Evaluation of Resistance Engendered by Amino Acid Substitutions in the Enzyme's Substrate Binding Site(1994)54 cited
- → Recalibration of theKLLAuger spectrum of carbon(1985)49 cited
- → Binding Model for Nonpeptide Antagonists of αvβ3 Integrin(2002)48 cited
- → Prediction Accuracy of Production ADMET Models as a Function of Version: Activity Cliffs Rule(2022)27 cited